ARC in Critical Ill OLT Recipients: True Prevalence, Risk Factors, and Impact on Early Aggressive PK/PD Target Non‐Attainment of CI Beta‐Lactam Therapy for Posttransplant Gram‐Negative Infections

Documenti analoghi

• Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria
  di: Cecilia Bonazzetti, et al.
  Pubblicazione: (2024)
• Characterization of Beta‐Lactam Allergy and Outcomes Associated With Perioperative Antibiotic Choice in Renal Transplant Recipients
  di: Annelise Nolan, et al.
  Pubblicazione: (2025)
• Impact of Donor Radiographic Pneumonia on Posttransplant Recipient Outcomes and Microbiology
  di: Kevin D. He, et al.
  Pubblicazione: (2025)
• Posttransplant HBV Vaccine Compliance, Seroprotection, and Kinetics of Hepatitis B Surface Antibody in Thoracic Organ Transplant Recipients
  di: Chia‐Yu Chiu, et al.
  Pubblicazione: (2025)
• Impact of Advanced Age on Posttransplant Infections and Outcomes in Solid Organ Transplant Recipients: A Multicenter Cohort Study
  di: Sibel Altunisik Toplu, et al.
  Pubblicazione: (2026)